Eric J. Ende, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 15,000 shares at $2.45 ($37K) on 2022-05-27, disclosed to the SEC on 2022-05-31.
Open-market purchase of $37k AVDL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| AVDL | BUY | 2022-11-23 | $156K | — | Filing → |
| AVDL | BUY | 2022-06-01 | $78K | — | Filing → |
| AVDL | BUY | 2020-09-18 | $98K | — | Filing → |